Jeremy Gross work email
- Valid
- Valid
- Valid
Jeremy Gross personal email
Jeremy Gross phone numbers
Healthcare executive with over 25 years of consulting and Biotechnology experience, specializing in Manufacturing Network Strategy and Product Operations across Plasma Derived Therapies, Vaccines and Biologics. Excels in developing innovative product strategies for both Manufacturing and Commercial initiatives, including business development, external partner negotiations.• Demonstrated leadership managing a wide array of complex Plasma, Vaccines and Biotech projects, including global product launches, product acquisitions, and major network expansions.• Expert in financial analysis, project leadership, product launch, contract negotiations and manufacturing strategy.• Experienced in identifying, developing and presenting business cases to C-Suite Executive teams.• Extensive negotiation experience with external corporate partners, Governments and Non-Governmental Organizations such as UNICEF, Gavi and the Bill and Melinda Gates Foundation.• Knowledgeable of global commercial strategies and a deep understanding of the Plasma and Vaccines businesses. Chaired strategic meetings with global boards of health such as the WHO, EMA & CFDA to drive product strategies and corporate initiatives.
-
Vp, Global Head - Network StrategyCsl Jun 2020 - PresentMelbourne, Victoria, AuAs Head of Network Strategy, I am responsible for developing and maintaining an optimized, flexible Manufacturing Network for the CSL family of companies. To ensure CSL can reliably supply our patients over the next decade and beyond, my team and I work closely with R&D, Commercial, manufacturing sites, regulatory, quality and many other groups within Operations. Inputs from these functions coupled with modelling and analysis are used balance risk profiles and operational readiness in developing the priorities for the CSL Manufacturing network. -
Vp, Head Of Plasma Product OperationsTakeda Oct 2017 - Jun 2020Tokyo, Jp(Originally Shire from October 2017 to Jan 2019)Responsible for developing, maintaining, and ensuring implementation of manufacturing strategies for Takeda’s portfolio of Plasma Derived Therapies across a 10-year planning horizon. Established and maintain the Product Operating Model used to translate the medical and commercial goals of the Plasma portfolio into sustainable manufacturing strategies.• Coordinates across the Immunology and Hematology franchises, Manufacturing, R&D, Plasma Collection and the Plasma Business Unit to ensure commercial and pipeline plasma products have the appropriate internal and external capacities and lifecycle strategies to meet the needs of the 10-year brand plan.• Sponsor for the capacity increase program which will deliver a 65% increase in IG capacity from 2018 to 2023.• Sponsor for the Plasma “Facility of the Future” initiative chartered with modernizing, expanding and recapitalizing Takeda’s Plasma Manufacturing sites to meet patient demand, improve margins and achieve carbon neutrality.• Manufacturing Operations lead for plasma related business development opportunities including capacity and financial implications of potential asset acquisitions. • Responsible for incorporating “Plasma Economics” into financial modeling to optimize the plasma portfolio and forecast COGS impacts to first and last liter products as a result of sales forecasts, plasma yields and costs as well as manufacturing conversion costs.• Coordination with Supply Chain, Regulatory and plasma sourcing teams to maximize the flexibility of product supply throughout the evolution of strategic programs, new product licensures and plasma sourcing opportunities. -
Senior Director, Vaccines Strategy LeadPfizer Mar 2017 - Sep 2017New York, New York, Us• Leads the 10-year Vaccines Strategic Plan and implementation of key projects to drive growth of commercial assets, accelerate pipeline assets, and assess external opportunities.• Leads the implementation of Pfizer Innovative Health initiatives within the Vaccines Business Unit to ensure alignment with the Enterprise on major corporate initiatives.• Partners across functional areas such as Medical, R&D, Information Technology & Human Resources to ensure the execution of key initiatives and assessment of growth opportunities. -
Senior Director, Prevenar Product Lead, Pfizer Global SupplyPfizer Jul 2016 - Mar 2017New York, New York, UsResponsible for integrating, influencing and shaping commercial strategies into the overall supply and manufacturing life-cycle strategy for Prevenar 13, Pfizer’s top-selling product, and the top-selling vaccine in the world.• Leader of a matrixed team comprised of Manufacturing, Quality, Regulatory, Supply Chain, Finance and technical experts dedicated to the near and long-term supply of Prevenar 13.• India NIP & Gavi Volume Guarantee: Leveraged 4 years of experience negotiating with The Gavi Alliance, Bill & Melinda Gates Foundation and UNCIEF to develop a supply and pricing strategy that provides Pfizer incremental volume over three years and enabled the start of the first ever Universal Immunization Program for PCV in India.• Emergency Humanitarian Relief: Partnered with UNICEF on the Supply Agreement that allowed Pfizer, for the first time ever, to supply Prevenar 13 at the Gavi price to populations in crisis.
-
Senior Director, Vaccines Product Portfolio Management & OperationsPfizer May 2015 - Jun 2016New York, New York, Us• Product Operations lead for Prevenar 13 and the balance of the Pfizer Vaccines portfolio. Key responsibilities included: - Manufacturing lead on the Vaccines Emerging Market Leadership teams (LatAM, AfME and AsiaPac). - Vaccines lead for all institutional business, including supply and contract negotiations with Gavi, Gates, PAHO & UNICEF. - Developing and maintaining the vaccine capacity and financial models used to drive product strategy.• Manufacturing lead for the Baxter and GSK vaccine acquisitions. Led the due diligence, contract negotiations and integration activities. Both integrations closed on time and have exceeded revenue expectations.• Gavi Contract Negotiations: Developed a novel modification to the three Gavi Contracts resulting in an incremental volumes for Pfizer and reduced costs to the Gavi countries.
-
Director, Vaccine Product OperationsPfizer Feb 2011 - May 2015New York, New York, UsFacilitates the cross-site, multi-functional Prevenar Product Team to develop product design solutions and manage value chain improvement opportunities which are in line with the objectives of the customer requirements. The DVPO is accountable to the Manufacturing and Supply organization, and in particular the Commercial Business Unit to ensure product/portfolio objectives, critical tradeoffs, and business plan milestones are achieved while increasing operational excellence throughout the life-cycle of the Vaccine portfolio.Other key responsibilities include:• Oversight of vaccines technology transfer projects, both internally and externally to the Pfizer manufacturing organization. Involvement in these projects includes business case development, assurance of supply continuity, and overall integration into the broader Pfizer vaccines manufacturing network.• Ensuring that Pfizer’s Plant Network Strategy (PNS) is aligned with the needs and requirements of site operations, quality, regulatory and supply chain functions and that each tech transfer delivers upon the commercial needs of the business.• Serves as Pfizer Global Supply’s (PGS) primary point of contact with the GAVI Alliance, UNICEF & PAHO in support of Pfizer’s 740-million dose, 13-year commitment to supply Prevenar 13 to the World’s poorest nations.
-
PrincipalPma Consultants Jun 2001 - Feb 2011Detroit, Mi, UsProgressed from dedicated management consulting role, to managing a staff of over 20 consultants across two regional offices in Philadelphia, PA and San Juan, Puerto Rico. Developed a client base that included Johnson & Johnson, Wyeth, Amgen, MedImmune and BP.• Prevenar 13: Supported the Senior Director of Vaccines Product Operations in the development and maintenance of the integrated schedule of strategic manufacturing projects, Prevenar capacity and financial models.• MedImmune: Engaged by MedImmune to lead a team working for the timely completion of the Corrective Actions / Preventative Actions (CAPA’s) generated from a MHRA audit. During the follow-up MHRA audit, zero critical and zero major observations were made.• Wyeth: Led a 12-person team of consultants and colleagues tasked with planning the process validation activities necessary to file Prevenar 13 with the EMA by December 5, 2008. After the successful completion of the EU and US filings for Prevenar 13, responsibilities transitioned to the management of the Strategic Product Agenda; the capacity, yield and cross-licensing projects required to meet the forecasted demand for Prevenar 13.• Johnson & Johnson: Lead a team of Project Controls professionals responsible for the global roll out and management of corporate cost, schedule and document control standards across J&J’s major capital projects. -
Senior ConsultantIntecap 1999 - 2001Woking, Surrey, UsAs a Senior Consultant in InteCap’s Boston office, worked on project management engagements, construction claims and litigation work. Served as the technical lead on projects centered on structural design or schedule related issues. Authored position papers, technical graphics and presentations for mediations, arbitrations and trials, and served as an expert witness at several mediations and arbitrations. -
Project EngineerLemessurier Consultants 1998 - 1999Provided structural design services on a wide range or projects ranging in size from 20,000 to 600,000 square feet.
-
Project EngineerAberjona Engineering 1994 - 1998Provided structural design services on a wide variety of projects including luxury houses, retail, office and collegiate athletic facilities.
Jeremy Gross Skills
Jeremy Gross Education Details
-
Bucknell UniversityCivil Engineering -
Bucknell UniversityStructural Engineering
-
Newton North High School
Frequently Asked Questions about Jeremy Gross
What company does Jeremy Gross work for?
Jeremy Gross works for Csl
What is Jeremy Gross's role at the current company?
Jeremy Gross's current role is Global Head - Network Strategy at CSL.
What is Jeremy Gross's email address?
Jeremy Gross's email address is je****@****ing.com
What is Jeremy Gross's direct phone number?
Jeremy Gross's direct phone number is +121257*****
What schools did Jeremy Gross attend?
Jeremy Gross attended Bucknell University, Bucknell University, Newton North High School.
What skills is Jeremy Gross known for?
Jeremy Gross has skills like Project Planning, Project Management, Biopharmaceuticals, Validation, Biotechnology, Pharmaceutical Industry, Management, Technology Transfer, Vaccines, Construction, Project Control, Leadership.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial